Abstract

Discoid lupus erythematosus (DLE) and systemic lupus erythematosus (SLE) are both types of lupus, yet the characteristics, and differences between them are not fully understood. Here we show single-cell RNA sequencing data of cutaneous lesions from DLE and SLE patients and skin tissues from healthy controls (HCs). We find significantly higher proportions of T cells, B cells and NK cells in DLE than in SLE. Expanded CCL20+ keratinocyte, CXCL1+ fibroblast, ISGhiCD4/CD8 T cell, ISGhi plasma cell, pDC, and NK subclusters are identified in DLE and SLE compared to HC. In addition, we observe higher cell communication scores between cell types such as fibroblasts and macrophage/dendritic cells in cutaneous lesions of DLE and SLE compared to HC. In summary, we clarify the heterogeneous characteristics in cutaneous lesions between DLE and SLE, and discover some specific cell subtypes and ligand-receptor pairs that indicate possible therapeutic targets of lupus erythematosus.

Discoid lupus erythematosus (DLE) and systemic LE (SLE) can present as cutaneous lesions. Here the authors characterise an scRNA dataset of cutaneous lesions from these patients and compare these to healthy controls showing differential immune cell recruitment, cell type and gene expression.

Details

Title
Single-cell sequencing shows cellular heterogeneity of cutaneous lesions in lupus erythematosus
Author
Zheng, Meiling 1 ; Hu, Zhi 1 ; Mei, Xiaole 2 ; Ouyang, Lianlian 1 ; Song, Yang 1 ; Zhou, Wenhui 1 ; Kong, Yi 1 ; Wu, Ruifang 1 ; Rao, Shijia 1 ; Long, Hai 1 ; Shi, Wei 3 ; Jing, Hui 1 ; Lu, Shuang 1 ; Wu, Haijing 1 ; Jia, Sujie 4 ; Lu, Qianjin 5   VIAFID ORCID Logo  ; Zhao, Ming 1   VIAFID ORCID Logo 

 Central South University, Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, Second Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); Chinese Academy of Medical Sciences, Research Unit of Key Technologies of Diagnosis and Treatment for Immune-related Skin Diseases, Changsha, China (GRID:grid.216417.7) 
 Chinese Academy of Medical Sciences and Peking Union Medical College, Institute of Dermatology, Nanjing, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
 Central South University, Department of Dermatology, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
 Central South University, Department of Pharmacy, The Third Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
 Central South University, Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, Second Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); Chinese Academy of Medical Sciences, Research Unit of Key Technologies of Diagnosis and Treatment for Immune-related Skin Diseases, Changsha, China (GRID:grid.216417.7); Chinese Academy of Medical Sciences and Peking Union Medical College, Institute of Dermatology, Nanjing, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2746829237
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.